DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Exelixis (NASDAQ: EXEL)



company name or ticker

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

The Surprising Thing Most of 2014's Top 10 Stocks Have in Common

8 out of 10 of last year's best-performing stocks have this one important common denominator.

Exelixis (EXEL) Is Today's Strong On High Volume Stock

Update: My Take On Exelixis' New Agreement With Sobi To Provide COMETRIQ In Europe

3 Biotech Stocks That Could Trounce Gilead Sciences, Inc. in 2015

Gilead Sciences may look cheap, but three of our top analysts believe these three other biotech stocks could have an even better 2015.

Does This Drug Offer Exelixis Inc. Investors Hope for the Future?

A potential approval of Exelixis' cobimetinib in 2015 could help restore investors' confidence -- but risk remains.

19 Lesser-Known Biotech Stocks With Robust Drug Pipelines

3 Biotech Stocks That Could Double in 2015

Three Motley Fool contributors tell us which biotech stocks they think could make a big move next year.

5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and ...

3 Clinical Stage Biotech Stocks That Should Be on Your Watchlist in 2015

Three Motley Fool analysts tell us which emerging biotechnology stocks they're watching in 2015.
See More Articles...